Samuel Ocasio

Dr. Samuel Ocasio

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
Luis Horacio Pagan RiveraLuis Horacio Pagan Rivera
Luis Horacio Pagan Rivera
FGFilipa Godoy-Vitorino
Filipa Godoy-Vitorino
Natalie M. Meléndez-VázquezNatalie M. Meléndez-Vázquez
Natalie M. Meléndez-Vázquez
SOSamuel Ocasio
Samuel Ocasio
MSMaría E. Santiago-Gascot
María E. Santiago-Gascot
JMJorge David Miranda
Jorge David Miranda
Spinal cord injury (SCI) is a devastating neurological state that could lead to motor, sensory, and autonomic dysfunction. In addition to its direct impact on the central nervous system, SCI exerts systemic effects, including disruption of gut homeostasis and alterations in the gut microbiota, which can contribute to sustained inflammation and hinder functional recovery. While antibiotic administration during the acute phase of SCI is clinically indicated, it may exacerbate microbial dysbiosis. In this study, we investigate the combined effects of SCI and cefazolin treatment on the gut microbiome of female rats. Animals were assigned to three groups: NAÏVE (no intervention), SHAM (cefazolin only), and INJURY (T10 spinal cord contusion plus cefazolin). Cefazolin was administered for seven days after the injury, fecal samples were collected at baseline (day 0), and on days 7, 14, 21, and 28 post-SCI. DNA was extracted and subjected to 16S rRNA gene amplicon sequencing, followed by bioinformatic analysis. Our findings revealed significant microbial dysbiosis in the INJURY group, including reduced alpha diversity and distinct shifts in microbial composition. These changes were most prominent during the acute phase post-SCI. Our findings highlight the compounding effects of spinal trauma and antibiotic exposure on the gut microbiome and suggest that maintaining microbial stability may represent a promising avenue to support recovery after SCI.

21 July 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
Luis Horacio Pagan RiveraLuis Horacio Pagan Rivera
Luis Horacio Pagan Rivera
FGFilipa Godoy-Vitorino
Filipa Godoy-Vitorino
Natalie M. Meléndez-VázquezNatalie M. Meléndez-Vázquez
Natalie M. Meléndez-Vázquez
SOSamuel Ocasio
Samuel Ocasio
MSMaría E. Santiago-Gascot
María E. Santiago-Gascot
JMJorge David Miranda
Jorge David Miranda
Spinal cord injury (SCI) is a devastating neurological state that could lead to motor, sensory, and autonomic dysfunction. In addition to its direct impact on the central nervous system, SCI exerts systemic effects, including disruption of gut homeostasis and alterations in the gut microbiota, which can contribute to sustained inflammation and hinder functional recovery. While antibiotic administration during the acute phase of SCI is clinically indicated, it may exacerbate microbial dysbiosis. In this study, we investigate the combined effects of SCI and cefazolin treatment on the gut microbiome of female rats. Animals were assigned to three groups: NAÏVE (no intervention), SHAM (cefazolin only), and INJURY (T10 spinal cord contusion plus cefazolin). Cefazolin was administered for seven days after the injury, fecal samples were collected at baseline (day 0), and on days 7, 14, 21, and 28 post-SCI. DNA was extracted and subjected to 16S rRNA gene amplicon sequencing, followed by bioinformatic analysis. Our findings revealed significant microbial dysbiosis in the INJURY group, including reduced alpha diversity and distinct shifts in microbial composition. These changes were most prominent during the acute phase post-SCI. Our findings highlight the compounding effects of spinal trauma and antibiotic exposure on the gut microbiome and underscore the importance of microbial stability in SCI recovery.

Verified
Journal Article
Open access
PDF file
Luis Horacio Pagan RiveraLuis Horacio Pagan Rivera
Luis Horacio Pagan Rivera
FGFilipa Godoy-Vitorino
Filipa Godoy-Vitorino
SOSamuel Ocasio
Samuel Ocasio
MSMaria E. Santiago-Gascot
Maria E. Santiago-Gascot
VGViviana González
Viviana González
JMJorge David Miranda
Jorge David Miranda
Spinal cord injury (SCI) triggers complex secondary injury cascades that limit neurological recovery. Tamoxifen (TAM), a selective estrogen receptor modulator, exerts neuroprotective effects in experimental SCI, although its underlying mechanisms remain unknown. Given the emerging role of gut microbiota dysregulation in SCI, we investigated whether TAM-associated recovery is accompanied by alterations in gut microbial composition and predicted function. We conducted a longitudinal, sex-inclusive analysis of 61 Sprague–Dawley rats of both sexes assigned to naïve (NAÏVE), sham-placebo (SHAM PLB), sham-TAM (SHAM TAM), injured-placebo (INJ PLB), or injured-TAM (INJ TAM) groups. Injured animals received a moderate T10 contusion followed by a 21-day TAM (0.71 mg/day) or placebo pellet, and fecal samples were collected at 0, 7, 14, 21, and 28 days post-injury. Fecal samples were analyzed by 16S rRNA gene sequencing. Results showed that TAM induced sustained shifts in microbial community composition, with treatment-associated divergence emerging at 14 days post-injury (DPI) in females and 21 DPI in males. Bifidobacterium exhibited the most consistent TAM-associated enrichment across sexes. Bifidobacterium abundance was negatively associated with recovery in INJ PLB animals and positively associated with INJ TAM animals; because behavioral and microbiome measurements were not made in the same animals, these associations are hypothesis-generating only. PICRUSt2 analysis revealed TAM-associated changes in predicted microbial function, including increased glycogen degradation pathways from 14 DPI onward in both sexes. Together, these findings identify sustained TAM-associated taxonomic and predicted functional remodeling of the gut microbiota following SCI.